KeyBank National Association’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,775
Closed -$235K 1054
2023
Q1
$235K Sell
22,775
-2,250
-9% -$28.8K ﹤0.01% 966
2022
Q4
$345K Buy
25,025
+8,343
+50% +$116K ﹤0.01% 828
2022
Q3
$341K Sell
16,682
-753
-4% -$16.5K ﹤0.01% 800
2022
Q2
$337K Buy
17,435
+1,275
+8% +$26.1K ﹤0.01% 829
2022
Q1
$348K Sell
16,160
-5,655
-26% -$128K ﹤0.01% 857
2021
Q4
$602K Sell
21,815
-1,190
-5% -$32.8K ﹤0.01% 746
2021
Q3
$597K Sell
23,005
-900
-4% -$24.1K ﹤0.01% 733
2021
Q2
$649K Sell
23,905
-15,995
-40% -$391K ﹤0.01% 717
2021
Q1
$934K Sell
39,900
-17,950
-31% -$363K ﹤0.01% 595
2020
Q4
$887K Sell
57,850
-10,425
-15% -$132K ﹤0.01% 564
2020
Q3
$823K Buy
68,275
+1,875
+3% +$17.8K ﹤0.01% 548
2020
Q2
$675K Sell
66,400
-150
-0.2% -$1.55K ﹤0.01% 591
2020
Q1
$694K Buy
66,550
+2,250
+3% +$28.2K ﹤0.01% 532
2019
Q4
$1.03M Buy
64,300
+5,875
+10% +$89.7K 0.01% 523
2019
Q3
$1.08M Sell
58,425
-8,245
-12% -$161K 0.01% 480
2019
Q2
$1.31M Buy
66,670
+19,650
+42% +$400K 0.01% 462
2019
Q1
$1.07M Buy
47,020
+12,145
+35% +$264K 0.01% 491
2018
Q4
$702K Buy
34,875
+16,050
+85% +$332K ﹤0.01% 582
2018
Q3
$409K Buy
+18,825
New +$418K ﹤0.01% 820
2014
Q3
Sell
-12,700
Closed -$207K 1226
2014
Q2
$207K Hold
12,700
﹤0.01% 1204
2014
Q1
$200K Hold
12,700
﹤0.01% 1214
2013
Q4
$218K Sell
12,700
-7,500
-37% -$115K ﹤0.01% 1168
2013
Q3
$267K Hold
20,200
﹤0.01% 1091
2013
Q2
$228K Buy
+20,200
New +$215K ﹤0.01% 1205

Other funds holding ANGO

KeyBank National Association's ANGO Position: Q2 2023 in Review

KeyBank National Association sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 22,775 shares — an estimated $235K sold.

KeyBank National Association first reported a position in ANGO in Q2 2013 and held it in 24 quarters. The position peaked at $1.31M in Q2 2019. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

  • KeyBank National Association reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
  • KeyBank National Association sold 22,775 AngioDynamics shares in Q2 2023, an estimated $235K.
  • KeyBank National Association first reported a position in AngioDynamics in Q2 2013 and held it in 24 quarters.
  • KeyBank National Association's AngioDynamics position peaked at $1.31M in Q2 2019.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on KeyBank National Association's 13F filing for Q2 2023, filed 1 Aug 2023.